5 |
asco.org
|
847 000 |
-2
|
2014-07-21
|
9 |
abiraterone clinical trials
|
53 400 |
0
|
2013-11-19
|
9 |
asco abstracts
|
316 000 |
0
|
2014-06-24
|
9 |
astro mee model
|
3 830 000 |
0
|
2014-05-05
|
10 |
asco conference
|
364 000 |
7
|
2014-09-30
|
12 |
asco meeting
|
1 510 000 |
0
|
2014-09-22
|
13 |
MITO 366 PC SUITE
|
43 300 |
0
|
2015-05-28
|
13 |
hormone refractory prostate cancer
|
218 000 |
0
|
2014-12-10
|
13 |
nephrectomy
|
1 030 000 |
29
|
2014-08-14
|
14 |
American Society of Clinical Oncology
|
6 210 000 |
0
|
2014-09-30
|
14 |
asco cancer
|
7 320 000 |
3
|
2014-07-26
|
16 |
jai gurudatta astro reviews
|
7 870 |
0
|
2014-01-21
|
16 |
PC Active
|
183 000 000 |
12
|
2014-07-24
|
17 |
Online Exhibitor Manual
|
328 000 |
0
|
2014-01-22
|
17 |
road works trial pc
|
1 040 000 |
0
|
2014-11-14
|
19 |
que asco
|
447 000 |
0
|
2014-06-03
|
21 |
t1a kidney cancer
|
9 290 |
12
|
2014-08-18
|
22 |
asco guidelines
|
308 000 |
0
|
2014-10-21
|
23 |
aganda program
|
247 000 000 |
0
|
2015-05-26
|
24 |
ags cancer treatment
|
78 300 |
0
|
2014-03-10
|
25 |
crouzet plc torrent
|
36 400 |
0
|
2014-02-28
|
25 |
guc grades calculation
|
680 000 |
0
|
2013-10-26
|
29 |
is angiomyolypoma cancer
|
73 500 |
-7
|
2014-09-26
|
29 |
asco ehr symposium show
|
360 000 |
0
|
2014-08-26
|
29 |
allowing users to self assess their knowledge
|
8 390 000 |
0
|
2015-03-30
|
30 |
definition antitumorigenic agent
|
90 200 |
15
|
2015-03-23
|
30 |
salvage rt 34
|
1 180 000 |
0
|
2016-10-29
|
32 |
merit awards
|
12 200 000 |
0
|
2013-11-02
|
34 |
astro learning
|
1 270 000 |
0
|
2014-12-22
|
34 |
muscle cancer
|
93 700 000 |
0
|
2014-10-05
|
36 |
author matthew heidenreich
|
101 000 |
0
|
2015-05-21
|
37 |
pcsuite mito 270
|
1 720 |
0
|
2015-06-03
|
37 |
convert powerpoint jpg to pot
|
76 800 000 |
0
|
2014-03-09
|
41 |
asco conference 2010
|
134 000 |
0
|
2014-07-29
|
41 |
world medical history urethral cancer
|
493 000 |
0
|
2014-07-24
|
43 |
portfolio membership
|
67 500 000 |
0
|
2016-03-24
|
44 |
gtx pancreatic asco 2011
|
84 000 |
0
|
2014-04-18
|
44 |
targeted therapy
|
10 300 000 |
0
|
2014-09-09
|